Co-Operative Pain Education and Self-management (COPES) Expanding Treatment for Real-World Access (ExTRA): Pragmatic Trial Protocol.
Co-Operative Pain Education and Self-management (COPES) Expanding Treatment for Real-World Access (ExTRA): Pragmatic Trial Protocol.
复制标题
DOI:
10.1093/pm/pnaa365
复制
发表时间:
2020-12-12
期刊:
影响因子:
--
通讯作者:
Higgins DM
中科院分区:
文献类型:
--
作者:
Heapy AA;Driscoll MA;Buta E;LaChappelle KM;Edmond S;Krein SL;Piette JD;Mattocks K;Murphy JL;DeBar L;MacLean RR;Ankawi B;Kawecki T;Martino S;Wagner T;Higgins DM
Given access barriers to cognitive behavioral therapy for chronic pain (CBT-CP), this pragmatic superiority trial will determine whether a remotely delivered CBT-CP intervention that addresses these barriers outperforms in-person and other synchronous forms of CBT-CP for veterans with musculoskeletal pain. This pragmatic trial compares an asynchronous form of CBT-CP that uses interactive voice response (IVR) to allow patients to participate from their home (IVR CBT-CP) with synchronous CBT-CP delivered by a Department of Veterans Affairs (VA) clinician. Veterans (n=764; 50% male) with chronic musculoskeletal pain throughout nine VA medical centers will participate. The primary outcome is pain interference after treatment (4 months). Secondary outcomes, including pain intensity, depression symptom severity, sleep, self-efficacy, and global impression of change, are also measured after treatment. Where possible, outcomes are collected via electronic health record extraction, with remaining measures collected via IVR calls to maintain blinding. Quantitative and qualitative process evaluation metrics will be collected to evaluate factors related to implementation. A budget impact analysis will be performed. This pragmatic trial compares the outcomes, cost, and implementation of two forms of CBT-CP as delivered in the real-world setting. Findings from the trial can be used to guide future policy and implementation efforts related to these interventions and their use in the health system. If one of the interventions emerges as superior, resources can be directed to this modality. If both treatments are effective, patient preferences and health care system factors will take precedence when making referrals. Implications of COVID-19 on treatment provision and trial outcomes are discussed.
登录
查看更多内容
DOI:
10.1186/1748-5908-4-50
发表时间:
2009-08-07
期刊:
Implementation science : IS
影响因子:
--
作者:
Damschroder LJ;Aron DC;Keith RE;Kirsh SR;Alexander JA;Lowery JC
通讯作者:
Lowery JC
影响因子:
4.5
作者:
Sullivan, Sean D.;Mauskopf, Josephine A.;Shau, Wen-Yi
通讯作者:
Shau, Wen-Yi
影响因子:
4.8
作者:
Bastien, Celyne H.;Vallieres, Annie;Morin, Charles M.
通讯作者:
Morin, Charles M.
影响因子:
7.4
作者:
Jensen, MP;Keefe, FJ;Turner, JA
通讯作者:
Turner, JA
影响因子:
5.7
作者:
Krebs, Erin E.;Lorenz, Karl A.;Bair, Matthew J.;Damush, Teresa M.;Wu, Jingwei;Sutherland, Jason M.;Asch, Steven M.;Kroenke, Kurt
通讯作者:
Kroenke, Kurt